| 1 | Monitoring Stem Cell Therapy In
Vivo J.W.M. Bulte, T. Douglas, B. Witwer, S-C. Zhang, B.K. Lewis, P.van Gelderen, I.D. Duncan, J.A. Frank. Laboratory of Diagnostic Radiology Research (CC), National Institutes of Health, Bethesda, MD |
| 2 | Dendritic Cell-Tumor Fusions As Immunotherapy:
A Phase I Clinical Trial in Patients with Metastatic Renal Cancer Avigan, David1; Atkins, Michael1; Gong, Jianling1; Uhl, Lynne1; Smith, Therese1; Wu, Zekui2; Vasir, Baldev2; Mier, James1; Gollob, Jared1; McDermott, David1; Borges, Virginia1; Stone, Carolyn1; Schadt, Kimberly1; Tetreault, Jean Claude1; Kufe, Donald2 1Hematology Oncology, Beth Israel Deaconess Medical Center Boston, MA; 2Adult Oncology, Dana Farber Cancer Institute Boston, MA |
| 3 | Poly(ADP-Ribose) Polymerase Role
in the Repair of Topoisomerase L -Induced DNA Damage JM Barceló1, G Kholhagen1, A van Hattum1, CM Simbulan-Rosenthal2,ME Smulson2,Y Pommier1 1Laboratory of Molecular Pharmacology, CCR, NCI, NIH; 2Department of Biochemistry and Molecular Biology, Georgetown University School of Medicine, Washington DC |
| 4 | Elimination of well-established metastases
by adoptively transferred, IL2-activated NK (A-NK) correlates
with their ability to localize to the malignant tissue Basse, Per; Yang, Yuqing; Herberman, Ronald University of Pittsburgh Cancer Institute, Pittsburgh, PA |
| 5 | Preferential apoptosis of CD56+dim natural
killer cell subset in patients with cancer Thomas Bauernhofer, Iris Kuss, Brent Henderson, Andrew S. Baum, Theresa L. Whiteside University of Pittsburgh Cancer Institute, Pittsburgh, PA |
| 6 | Higher onset of apoptosis of circulating T-lymphocytes
does not correlate with prolactin receptor expression and prolactin
plasma levels in patients with breast cancer Thomas Bauernhofer, Ulrike Friebe-Hoffmann, Grzegorz Dworacki, Barbara Vonderhaar, Andrew S. Baum, Theresa L. Whiteside University of Pittsburgh Cancer Institute, Pittsburgh, PA and NCI, NIH, Bethesda, MD |
| 7 | Human U251-MG Glioma Cells Expressing the Membrane
Form of Macrophage Colony Stimulating Factor (mM-CSF) are Killed
by Human Monocytes In Vitro and Are Rejected in Immunodeficient
Mice Chen Y, Jadus MR, Lloyd C, Sanchez R, Delgado C, Wepsic HT Diagnostic and Molecular Medicine Health Care Group, Veterans Affairs Medical Center, Long Beach, CA; Pathology Department, University of California, Irvine, CA |
| 8 | Apo2-L/TRAIL-induced apoptosis in 4 leukemic
cell lines is not enhanced by hyperthermia in vitro Jinrong Cheng, Elizabeth Repasky Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY |
| 9 | Characterization of autologous activated lymphocytes
used for adoptive immunotherapy of renal cell and colon carcinoma Cornforth, AN, Schiltz PM, Nayak SK, Dillman RO Hoag Cancer Center, Newport Beach, CA |
| 10 | Murine Hepatoma Hepa1-6 cells Expressing the
Membrane Form of Macrophage Colony Stimulating Factor (mM-CSF)
are Killed by Macrophages In Vitro and Lead to Tumor Rejection
and Immunization Against the Parental Tumor In Vivo by CD8+
T Cells Dan Q, Wepsic HT, Morgan K, Sanchez R, Morgan TR, Jadus MR Veterans Affairs Medical Center Long Beach CA and University of California Irvine |
| 11 | 4T1 Mammary Tumor Suppresses B- and T-cell
Function In Vivo Erika A. Danna, Beth A. Pulaski, Mileka Gilbert, and Suzanne Ostrand-Rosenberg Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD |
| 12 | Delayed type hypersensitivity skin testing
with irradiated autologous tumor cells: association with survival
during treatment with autologous tumor cell vaccine Dillman RO, DePriest C, Beutel LD, Barth NM, de Leon C, O’Connor A, Nayak SK Hoag Cancer Center, Newport Beach, CA |
